Evidence map›Paper›PMID 36094082›Full record

ArticlemSystems2022

Phosphoproteome Dynamics of Streptomyces rimosus during Submerged Growth and Antibiotic Production.

Ela Šarić, Gerry A Quinn, Nicolas Nalpas, Tina Paradžik, Saša Kazazić, Želimira Filić, Maja Šemanjski, Paul Herron, Iain Hunter, Boris Maček and 1 more

Open access · goldAbstract read
In one paragraph

Article in mSystems, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Modulating Complex Secondary Metabolism inFood technology and biotechnology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Ela ŠarićDivision of Physical Chemistry, Institute Ruđer Bošković, Zagreb, Croatia.
Gerry A QuinnDivision of Physical Chemistry, Institute Ruđer Bošković, Zagreb, Croatia.ORCID 0000-0003-0023-2621
Nicolas NalpasProteome Center Tübingen, University of Tübingen, Tübingen, Germany.
Tina ParadžikDivision of Physical Chemistry, Institute Ruđer Bošković, Zagreb, Croatia.
Saša KazazićDivision of Physical Chemistry, Institute Ruđer Bošković, Zagreb, Croatia.
Želimira FilićDivision of Physical Chemistry, Institute Ruđer Bošković, Zagreb, Croatia.
Maja ŠemanjskiProteome Center Tübingen, University of Tübingen, Tübingen, Germany.
Paul HerronStrathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclydegrid.11984.35, Glasgow, United Kingdom.ORCID 0000-0003-3431-1803
Iain HunterStrathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclydegrid.11984.35, Glasgow, United Kingdom.
Boris MačekProteome Center Tübingen, University of Tübingen, Tübingen, Germany.
Dušica VujaklijaDivision of Physical Chemistry, Institute Ruđer Bošković, Zagreb, Croatia.ORCID 0000-0003-1184-1828
Ruđer Bošković Institute · HRUniversity of Tübingen · DEUniversity of Strathclyde · GBUniversity of Ulster · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Streptomyces rimosus is an industrial streptomycete, best known as a producer of oxytetracycline, one of the most widely used antibiotics. Despite the significant contribution of

Indexed as

OxytetracyclineStreptomycesStreptomyces rimosusAnti-Bacterial AgentsChromatography, LiquidPhosphoproteinsProteomeProteomicsTandem Mass SpectrometryAnti-Bacterial AgentsOxytetracyclinePhosphoproteinsProteomeoxytetracyclineoxytetracycline productionpellet fragmentationpeptide dimethylation labelingphosphoproteomeproteomeStreptomyces rimosus

Identifiers

PMID36094082
PMCPMC9600765
OpenAlexW4295292756

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.